Dianthus Therapeutics, Inc.

NasdaqCM:DNTH Stock Report

Market Cap: US$749.3m

Dianthus Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:DNTH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jan 24BuyUS$18,000,000Avidity Partners Management, L.P.Company1,500,000US$12.00
22 Jan 24BuyUS$10,012,008Fairmount Funds Management LLCCompany834,334US$12.00
22 Jan 24BuyUS$2,000,004Leon MoulderIndividual166,667US$12.00
29 Sep 23BuyUS$336,252Fairmount Funds Management LLCCompany24,670US$13.63
26 Sep 23BuyUS$394,500Fairmount Funds Management LLCCompany30,000US$13.15
22 Sep 23BuyUS$52,800Simrat RandhawaIndividual4,000US$13.20
19 Sep 23BuyUS$396,000Fairmount Funds Management LLCCompany30,000US$13.20
13 Sep 23BuyUS$271,680Fairmount Funds Management LLCCompany24,254US$11.76

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of DNTH?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders65,0280.222%
General Public921,8273.14%
Private Companies1,094,1803.73%
Hedge Funds5,480,39118.7%
VC/PE Firms8,259,69628.1%
Institutions13,528,34746.1%

Dilution of Shares: DNTH only recently listed within the past 12 months


Top Shareholders

Top 25 shareholders own 92.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.7%
FMR LLC
4,300,945US$109.8m3.36%0.01%
9.41%
Fairmount Funds Management LLC
2,762,837US$70.5m0%6.57%
9.26%
Avidity Partners Management, L.P.
2,717,554US$69.4m0%2.83%
8.04%
Bain Capital Life Sciences Investors, LLC
2,360,059US$60.3m-21.1%6.38%
7.95%
RA Capital Management, L.P.
2,333,000US$59.6m0%0.82%
7.14%
VR Adviser, LLC
2,094,373US$53.5m0%2.65%
5.02%
5AM Venture Management, LLC
1,472,264US$37.6m18.5%7.84%
4.9%
Tellus BioVentures, LLC
1,436,745US$36.7m0%no data
4.7%
Octagon Capital Advisors LP
1,380,667US$35.2m149%5.43%
3.71%
Viridian, LLC
1,090,283US$27.8m0%no data
2.27%
RTW Investments, LP
666,667US$17.0m0%0.29%
2.13%
Great Point Partners, LLC
625,000US$16.0m0%3.07%
1.83%
The Vanguard Group, Inc.
537,828US$13.7m250%no data
1.55%
Vestal Point Capital, LP
455,000US$11.6m237%1.05%
1.32%
Point72 Asset Management, L.P.
386,570US$9.9m0%0.02%
1.28%
Janus Henderson Group plc
375,044US$9.6m0%no data
1.02%
Adage Capital Management, L.P.
298,000US$7.6m0%0.01%
0.94%
Millennium Management LLC
277,213US$7.1m716%0.01%
0.9%
Tang Capital Management, LLC
264,692US$6.8m-47.5%0.87%
0.74%
Ally Bridge Group
216,968US$5.5m0%2.5%
0.71%
GV Management Company, LLC
208,697US$5.3m0%0.41%
0.7%
Susquehanna International Group, LLP, Asset Management Arm
205,487US$5.2m617%0.01%
0.65%
Walleye Capital LLC
190,266US$4.9m0%0.03%
0.64%
Atlas Venture L.P.
186,979US$4.8m-21.1%0.51%
0.58%
Goldman Sachs Group, Investment Banking and Securities Investments
170,217US$4.3m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.